American Autoimmune Related Diseases Association

In 1991, the American autoimmune related diseases association was established and its mission is the elimination of autoimmune diseases and also the alleviation of the suffering and socioeconomic impact of autoimmunity through initiating, fostering, and facilitating partnership in research, education, advocacy and patient services in an effective, ethical, and efficient manner. The treatment of autoimmune diseases is typically with immunosuppression—medication that reduces the immune response. New novel treatments include Cytokine, removal of effector T-cells and B-cells (e.g. anti-CD20 therapy can be productive at removing instigating B-cells). Intravenous Immunoglobulin has been helpful in treating some antibody mediated autoimmune disorders as well, possibly through negative feedback mechanisms. There are at least 80 types of autoimmune diseases are identified. A major comprehension of the underlying pathophysiology of autoimmune disorders has been the application of genome wide association scans that have identified a striking degree of genetic sharing among the autoimmune diseases. Autoimmune diseases have a wide diversity of different effects. They do tend to have one of three features pathological effects which characterize them as autoimmune diseases: Damage or destruction of tissues, Altered organ growth, Altered organ function.